Free Trial

Dermata Therapeutics (DRMAW) Short Interest Ratio & Short Volume

$0.0088 0.00 (0.00%)
(As of 11/22/2024 ET)

Dermata Therapeutics Short Interest Data

Dermata Therapeutics (DRMAW) has a short interest of 11,400 shares. This marks a -8.06% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.9, indicating that it would take 2.9 days of the average trading volume of 10,863 shares to cover all short positions.

Current Short Interest
11,400 shares
Previous Short Interest
12,400 shares
Change Vs. Previous Month
-8.06%
Dollar Volume Sold Short
$79.80
Short Interest Ratio
2.9 Days to Cover
Last Record Date
June 15, 2024
Today's Trading Volume
0 shares
Average Trading Volume
10,863 shares
Today's Volume Vs. Average
0%
Short Selling Dermata Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Dermata Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

DRMAW Short Interest Over Time

DRMAW Days to Cover Over Time

DRMAW Percentage of Float Shorted Over Time

Dermata Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202411,400 shares $79.80 -8.1%N/A2.9 $0.01
5/31/202412,400 shares $100.44 +11.7%N/A2.9 $0.01
5/15/202411,100 shares $187.59 -2.6%N/A2.2 $0.02
4/30/202411,400 shares $108.30 +3.6%N/A2.5 $0.01
4/15/202411,000 shares $101.20 +15.8%N/A2.2 $0.01
3/31/20249,500 shares $90.25 -24.6%N/A1.6 $0.01
3/15/202412,600 shares $141.12 +20.0%N/A2.2 $0.01
2/29/202410,500 shares $165.90 -8.7%N/A1.8 $0.02
2/15/202411,500 shares $143.75 +17.4%N/A2.3 $0.01
1/31/20249,800 shares $245.00 -26.3%N/A2 $0.03
1/15/202413,300 shares $275.31 +4.7%N/A3.2 $0.02
12/31/202312,700 shares $88.90 -0.8%N/A3.3 $0.01
12/15/202312,800 shares $281.60 No ChangeN/A4.6 $0.02
11/30/202312,800 shares $268.80 No ChangeN/A5.8 $0.02
11/15/202312,800 shares $157.44 No ChangeN/A3.9 $0.01
10/31/202312,800 shares $153.60 -2.3%N/A4 $0.01
10/15/202313,100 shares $327.50 No ChangeN/A3.9 $0.03
9/30/202313,100 shares $229.25 +1.6%N/A3.4 $0.02
9/15/202312,900 shares $313.47 -18.4%N/A2.3 $0.02
8/31/202315,800 shares $284.40 +16.2%N/A2.8 $0.02
8/15/202313,600 shares $390.32 -19.5%N/A2.3 $0.03
7/31/202316,900 shares $338.00 -18.0%N/A1.7 $0.02
7/15/202320,600 shares $587.10 +57.3%N/A1.6 $0.03
6/30/202313,100 shares $327.50 -5.8%N/A0.6 $0.03
6/15/202313,900 shares $223.79 +2.2%N/A0.6 $0.02
5/31/202313,600 shares $448.80 -26.1%N/A0.6 $0.03
5/15/202318,400 shares $276.00 No ChangeN/A0.8 $0.02
8/15/2022300 shares $44.04 -57.1%N/A0 $0.15
7/31/2022700 shares $58.80 -61.1%N/A0.1 $0.08
7/15/20221,800 shares $155.34 No ChangeN/A0.2 $0.09
4/30/2022500 shares $73.50 +25.0%N/A0 $0.15
4/15/2022400 shares $63.96 -55.6%N/A0 $0.16
3/31/2022900 shares $0.00 No ChangeN/A0.1 $0.00

DRMAW Short Interest - Frequently Asked Questions

What is Dermata Therapeutics' current short interest?

Short interest is the volume of Dermata Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 11,400 shares of DRMAW short. Learn More on Dermata Therapeutics' current short interest.

What is a good short interest ratio for Dermata Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DRMAW shares currently have a short interest ratio of 3.0. Learn More on Dermata Therapeutics's short interest ratio.

Is Dermata Therapeutics' short interest increasing or decreasing?

Dermata Therapeutics saw a drop in short interest in June. As of June 15th, there was short interest totaling 11,400 shares, a drop of 8.1% from the previous total of 12,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Dermata Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Dermata Therapeutics: Alvotech (0.07%), LAVA Therapeutics (0.13%), Mainz Biomed (8.71%), Pharvaris (0.76%), Procaps Group S.A. (0.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short Dermata Therapeutics stock?

Short selling DRMAW is an investing strategy that aims to generate trading profit from Dermata Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Dermata Therapeutics?

A short squeeze for Dermata Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DRMAW, which in turn drives the price of the stock up even further.

How often is Dermata Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRMAW, twice per month. The most recent reporting period available is June, 15 2024.




This page (NASDAQ:DRMAW) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners